An iron-based T1 contrast agent made of iron-phosphate complexes:: In vitro and in vivo studies

被引:15
|
作者
Rodriguez, Elisenda
Simoes, Rui V.
Roig, Anna
Molins, Elies
Nedelko, Nataliya
Slawska-Waniewska, Anna
Aime, Silvio
Arus, Carles
Cabanas, Miquel E.
Sanfeliu, Coral
Cerdan, Sebastian
Garcia-Martin, Maria Luisa
机构
[1] CSIC, ICMAB, Bellaterra 08193, Spain
[2] Univ Coimbra, Ctr Neurociencias & Biol Celular, Coimbra, Portugal
[3] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain
[4] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain
[5] CSIC, IDIBAPS, Inst Invest Biomed Barcelona, Barcelona 08036, Spain
[6] Univ Autonoma Barcelona, Serv RMN, Bellaterra 08193, Spain
[7] Univ Turin, Dipartimento Chim IFM, I-10125 Turin, Italy
[8] Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland
关键词
magnetic resonance imaging; T-1 contrast agent; Fe-8; iron phosphate particles; MRI; CLUSTER; GLIOMA; MODEL;
D O I
10.1007/s10334-006-0066-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A new iron-based T, contrast agent consisting of a complex of iron ions coordinated to phosphate and amine ligands (Fe-(phos) in short) has been characterized by spectroscopic and magnetic measurements. NMR relaxation studies showed r(1) values to be dependent on the phosphate salt concentration, K2HPO4, present in the medium. r(1) reaches a maximum value of 2.5 mM(-1) s(-1) for measurements carried out at 7 T and 298 K. P-31 MRS, Mossbauer spectroscopy and magnetic measurements of Fe(phos) solutions suggest paramagnetic Fe3+ ions present in the studied iron-phosphate complex. In vitro and in vivo toxicity experiments with C6 cells and CD1 mice, respectively, demonstrated lack of toxicity for Fe-(phos) at the highest dose tested in the MRI experiments (12 mM iron for C6 cells and 0.32 mmol iron/kg for mice). Finally, T-1 weighted images of brain tumours in mice have shown positive contrast enhancement of Fe-(phos) for tumour afflicted regions in the brain.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 49 条
  • [1] An iron-based T1 contrast agent made of iron-phosphate complexes: In vitro and in vivo studies
    Elisenda Rodríguez
    Rui V. Simoes
    Anna Roig
    Elies Molins
    Nataliya Nedelko
    Anna Ślawska-Waniewska
    Silvio Aime
    Carles Arús
    Miquel E. Cabañas
    Coral Sanfeliu
    Sebastián Cerdán
    Maria Luisa García-Martín
    Magnetic Resonance Materials in Physics, Biology and Medicine, 2007, 20 : 27 - 37
  • [2] Iron-based ferritin nanocore as a contrast agent
    Sana, Barindra
    Johnson, Eric
    Sheah, Kenneth
    Poh, Chueh Loo
    Lim, Sierin
    BIOINTERPHASES, 2010, 5 (03) : FA48 - FA52
  • [3] Iron Oxide Nanoparticle-Based T1 Contrast Agents for Magnetic Resonance Imaging: A Review
    Zhang, Dongmei
    Zhang, Jing
    Bian, Xianglin
    Zhang, Pei
    Wu, Weihua
    Zuo, Xudong
    NANOMATERIALS, 2025, 15 (01)
  • [4] Ultrasmall graphene oxide based T1 MRI contrast agent for in vitro and in vivo labeling of human mesenchymal stem cells
    Zhang, Mengxin
    Liu, Xiaoyun
    Huang, Jie
    Wang, Lina
    Shen, He
    Luo, Yu
    Li, Zhenjun
    Zhang, Hailu
    Deng, Zongwu
    Zhang, Zhijun
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (07) : 2475 - 2483
  • [5] Iron phosphide nanoparticles as a pH-responsive T1 contrast agent for magnetic resonance tumor imaging
    Qiu, Yuan
    Lin, Weiwen
    Wang, Lili
    Liu, Rui
    Xie, Jiangao
    Chen, Xin
    Yang, Feifei
    Huang, Guoming
    Yang, Huanghao
    RSC ADVANCES, 2019, 9 (52) : 30581 - 30584
  • [6] A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors
    Xue, Xiangdong
    Bo, Ruonan
    Qu, Haijing
    Jia, Bei
    Xiao, Wenwu
    Yuan, Ye
    Vapniarsky, Natalia
    Lindstrom, Aaron
    Wu, Hao
    Zhang, Dalin
    Li, Longmeng
    Ricci, Marina
    Ma, Zhao
    Zhu, Zheng
    Lin, Tzu-yin
    Louie, Angelique Y.
    Li, Yuanpei
    BIOMATERIALS, 2020, 257
  • [7] Tailor-Made Quantum Dot and Iron Oxide Based Contrast Agents for in Vitro and in Vivo Tumor Imaging
    Poeselt, Elmar
    Schmidtke, Christian
    Fischer, Steffen
    Peldschus, Kersten
    Salamon, Johannes
    Kloust, Hauke
    Huong Tran
    Pietsch, Andrea
    Heine, Markus
    Adam, Gerhard
    Schumacher, Udo
    Wagener, Christoph
    Foerster, Stephan
    Weller, Horst
    ACS NANO, 2012, 6 (04) : 3346 - 3355
  • [8] Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI
    Luedemann, Lutz
    Schmitt, Boris
    Podrabsky, Petr
    Schnackenburg, Bernhard
    Boeck, Johannes
    Gutberlet, Matthias
    EUROPEAN JOURNAL OF RADIOLOGY, 2007, 62 (02) : 247 - 256
  • [9] GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo
    Gulaka, Praveen K.
    Rojas-Quijano, Federico
    Kovacs, Zoltan
    Mason, Ralph P.
    Sherry, A. Dean
    Kodibagkar, Vikram D.
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2014, 19 (02): : 271 - 279
  • [10] Fe(deferasirox)2: An Iron(III)-Based Magnetic Resonance Imaging T1 Contrast Agent Endowed with Remarkable Molecular and Functional Characteristics
    Palagi, Lorenzo
    Di Gregorio, Enza
    Costanzo, Diana
    Stefania, Rachele
    Cavallotti, Camilla
    Capozza, Martina
    Aime, Silvio
    Gianolio, Eliana
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (35) : 14178 - 14188